These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5824728)

  • 41. Growth of leiomyomata with estrogen--progestogen therapy.
    John AH; Martin R
    J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282
    [No Abstract]   [Full Text] [Related]  

  • 42. Cancer risks from estrogen intake.
    Greenwald P; Nasca PC; Caputo TA; Janerich DT
    N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252
    [No Abstract]   [Full Text] [Related]  

  • 43. Changing oral contraceptives.
    Br Med J; 1969 Dec; 4(5686):789-91. PubMed ID: 5359946
    [No Abstract]   [Full Text] [Related]  

  • 44. [A further case of hepatocytic adenoma following oestrogen-progestogen treatment. Review of the published literature (author's transl)].
    Grandjean JP; Vignal J; Seffert P; Mestrallet G; Beurlet J; Quiviger P
    Ann Chir; 1979 May; 33(5):361-70. PubMed ID: 389138
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral contraceptives and cervical cancer. A preliminary report of an experimental study.
    Myhre E; Bjoro K
    Acta Pathol Microbiol Scand; 1969; 76(3):495-6. PubMed ID: 5823365
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cancer of the breast. Influence of hormonal contraception].
    Gorins A
    Presse Med; 1984 May; 13(19):1207-10. PubMed ID: 6232568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oral contraceptives: update].
    Fugère P
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract]   [Full Text] [Related]  

  • 48. [Arterial hypertension during treatment with estro-progestative agents].
    Dumont M; Pellissier B; Laforet J; Dick D
    J Med Lyon; 1971 Mar; 52(204):381-3. PubMed ID: 5135329
    [No Abstract]   [Full Text] [Related]  

  • 49. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
    Sturtevant FM
    Biomed Pharmacother; 1984; 38(8):371-9. PubMed ID: 6525434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol.
    Bulbrook RD; Herian M; Tong D; Hayward JL; Swain MC; Wang DY
    Lancet; 1973 Mar; 1(7804):628-31. PubMed ID: 4121844
    [No Abstract]   [Full Text] [Related]  

  • 51. Endometrial cancer with progestagen and oestrogen oral contraceptives.
    Grant ECG
    Lancet Oncol; 2015 Nov; 16(15):e527. PubMed ID: 26545838
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of side effects of current oral contraceptives.
    Nelson JH
    J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
    [No Abstract]   [Full Text] [Related]  

  • 53. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible hazards in estrogen administration.
    Allen W
    Cancer; 1969 Dec; 24(6):1137-9. PubMed ID: 5353958
    [No Abstract]   [Full Text] [Related]  

  • 56. Oral contraception and hormone replacement therapy: are progestogens and progestins breast mitogens?
    Vorherr H
    Am J Obstet Gynecol; 1986 Nov; 155(5):1140-2. PubMed ID: 3777063
    [No Abstract]   [Full Text] [Related]  

  • 57. [Trends in drug-hormone contraception].
    Kuemmerle HP
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):465-6. PubMed ID: 5718773
    [No Abstract]   [Full Text] [Related]  

  • 58. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
    Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptives and hypertension.
    Br Med J; 1970 May; 2(5706):378. PubMed ID: 5460571
    [No Abstract]   [Full Text] [Related]  

  • 60. [Estrogens and progestagens. (Progress--utility, hazards--abuse)].
    Holzmann K
    Munch Med Wochenschr; 1972 Feb; 114(6):217-27. PubMed ID: 5067172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.